S&P 500 (SPY) $739.08 +0.73%Nasdaq 100 (QQQ) $709.56 +1.14%Dow Jones (DIA) $498.77 +0.97%Russell 2000 (IWM) $278.66 +2.07%Gold (GLD) $416.20 +1.14%10Y Bond (TLT) $83.83 +0.98% S&P 500 (SPY) $739.08 +0.73%Nasdaq 100 (QQQ) $709.56 +1.14%Dow Jones (DIA) $498.77 +0.97%Russell 2000 (IWM) $278.66 +2.07%Gold (GLD) $416.20 +1.14%10Y Bond (TLT) $83.83 +0.98%
Earnings May 19, 2026 at 7:00 AM

BIO-Key International Inc Earnings: Beat on EPS Despite Revenue Miss

BIO-Key International Inc (BKYI) delivered a significant earnings beat for the quarter ended May 18, 2026, reporting an EPS loss of $0.15 versus analyst estimates of a $0.61 loss, representing a 75.49% positive surprise.

The company’s actual EPS of negative $0.15 came in $0.46 better than the consensus estimate of negative $0.61, marking a substantial improvement in per-share losses. This 75.49% earnings surprise demonstrates better-than-expected cost management and operational efficiency during the quarter.

Revenue performance told a different story, with BKYI generating $2.15 million in quarterly revenue compared to analyst expectations of $2.24 million. The $94,000 shortfall resulted in a 4.19% negative revenue surprise, indicating challenges in top-line growth despite the strong bottom-line performance.

The mixed results show BIO-Key’s ability to control expenses and minimize losses while facing headwinds in revenue generation, with the $2.15 million in actual sales falling short of the $2.24 million forecast by Wall Street analysts.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.